Insulin-Sensitizing Activity of Sub-Nanoscaled Polyalkoxyvanadate Clusters

Area of Science:

• Nanomaterials Science
• Biochemistry
• Endocrinology

Background:

• Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
• Insulin therapy is a cornerstone of diabetes management but faces challenges with glucose responsiveness and duration.
• Developing novel insulin sensitizers is crucial for improving glycemic control.

Purpose of the Study:

• To evaluate the insulin-sensitizing activity of sub-nanoscaled polyalkoxyvanadates (PAOVs) functionalized with aliphatic acids.
• To assess the efficacy of PAOVs in lowering blood glucose levels in diabetic mice.
• To investigate the potential of PAOVs to enhance insulin responsiveness and duration of action.

Main Methods:

• Oral administration of various PAOVs to diabetic mice.
• Glucose tolerance tests to assess blood glucose-lowering effects.
• Continuous glucose monitoring to evaluate insulin responsiveness and duration.

Main Results:

• All tested PAOVs restored normal blood glucose levels after single oral administration.
• Myristic acid-modified PAOVs prolonged insulin response to glucose challenges up to 13 hours.
• PAOVs, particularly capric and myristic acid-modified ones, enhanced insulin responsiveness, comparable to a clinical insulin derivative.
• Myristic acid-modified PAOVs demonstrated insulin responsiveness nearly matching that of a healthy pancreas.

Conclusions:

• Sub-nanoscaled PAOVs show significant potential as insulin sensitizers for diabetes management.
• PAOV functionalization with specific aliphatic acids can promote glucose-responsive and long-lasting insulin activity.
• These findings offer new therapeutic avenues for accurate blood glucose control in insulin therapy, potentially reducing administration frequency.